Now, a cure for age-related memory loss
Researchers at Princeton University have shown that two methods of extending life span have very different effects on memory performance and decline with age.
Washington: Researchers at Princeton University have shown that two methods of extending life span have very different effects on memory performance and decline with age.
While the nematode C. elegans is already well known for its utility in longevity research, previously it was not known how the memory of C. elegans compares with that of other animals, or whether longevity treatments could improve learning and memory.
To answer these questions, Amanda Kauffman and colleagues, of Coleen Murphy`s lab at Princeton, designed new tests of learning and memory in C. elegans, then used these tests to identify the necessary components of learning, short-term memory, and long-term memory. They found that the molecules required for learning and memory appear to be conserved from C. elegans to mammals, suggesting that the basic mechanisms underlying learning and memory are ancient.
The authors also determined how each of the behaviours declines with age, and tested the effects of two known regulators of longevity -- dietary restriction and reduced Insulin/IGF-1 signaling -- on these declines. Surprisingly, very different effects on memory were achieved with the two longevity treatments: dietary restriction impaired memory in early adulthood but maintained memory with age, while reduced Insulin/IGF-1 signaling improved early adult memory performance but failed to preserve it with age.
These results suggest not only that longevity treatments could help preserve cognitive function with age, but also that different longevity treatments might have very different effects on such declines.
Murphy said: "Since one of the most devastating age-related declines is the loss of memory, it is exciting that we now can use C. elegans as a model to understand not only longevity but also memory function.
"We hope to use the system now to identify new drugs and treatments for age-related cognitive decline. Maybe targeting more than one longevity pathway would be the right approach."
The study will publish in the online, open-access journal PLoS Biology.